TUMOR TREATING FIELDS (TTFIELDS) COMBINED WITH PACLITAXEL ENHANCES TREATMENT EFFICACY IN VITRO AND IN A MURINE MODEL OF OVARIAN CANCER

被引：0
|
作者：
Weinberg, U. [1 ]
Voloshin, T. [2 ]
Munster, M. [2 ]
Giladi, M. [2 ]
Schneiderman, R. [2 ]
Porat, Y. [2 ]
Bomzon, Z. [3 ]
Urman, N. [3 ]
Itzhaki, A. [4 ]
Cahal, S. [2 ]
Kirson, E. [5 ]
Palti, Y. [6 ]
机构：
[1] Novocure, Clin Dev, Root, Switzerland
[2] Novocure, Preclin, Haifa, Israel
[3] Novocure, Sci Affairs, Haifa, Israel
[4] Novocure, PreCln, Haifa, Israel
[5] Novocure, Res & Dev, Haifa, Israel
[6] Novocure, Haifa, Israel
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2017年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO7-0837
引用
收藏
页码：1710 / 1710
页数：1
相关论文
共 50 条
  • [21] The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed inhibit mesothelioma cells in vitro
    Munster, Mijal
    Schneiderman, Rosa
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Shteingauz, Anna
    Kayna, Noa
    Zeevi, Einav
    Gotlib, Karnit
    Giladi, Moshe
    Kirson, Eilon
    Weinberg, Uri
    Kinzel, Adrian
    Palti, Yoram
    CANCER RESEARCH, 2019, 79 (13)
  • [22] The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed Inhibit Mesothelioma Cells In Vitro
    Munster, M.
    Schneiderman, R. S.
    Porat, Y.
    Voloshin, T.
    Davidi, S.
    Shteingauz, A.
    Kaynan, N.
    Zeevi, E.
    Gotlib, K.
    Giladi, M.
    Kirson, E.
    Weinberg, U.
    Kinzel, A.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (01): : 239 - 239
  • [23] TRIFLOUROPROMAZINE, AN APPROVED ANTIPSYCHOTIC DRUG, ENHANCES TUMOR TREATING FIELDS TREATMENT EFFICACY IN VITRO
    Porat, Yaara
    Giladi, Moshe
    Schneiderman, Roza
    Munster, Mijal
    Blatt, Roni
    Weinberg, Uri
    Kirson, Eilon
    Palti, Yoram
    NEURO-ONCOLOGY, 2014, 16
  • [24] Tumor treating fields (TTFields; 150 kHz) and FOLFOX combination treatment effects on gastric cancer in vitro
    Zeevi, Einav
    Gotlib, Karnit
    Schneiderman, Rosa S.
    Munster, Mijal
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Shteingauz, Anna
    Kaynan, Noa
    Giladi, Moshe
    Kirson, Eilon D.
    Weinberg, Uri
    Kinzel, Adrian
    Palti, Yoram
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [25] Efficacy of concomitant application of Tumor Treating Fields (TTFields), temozolomide and lomustine in glio blastoma cancer cells in vitro
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Concomitant treatment of ovarian cell lines with Tumor Treating Fields (TTFields) and PARP inhibitors
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Translational study of tumor treating fields in combination with paclitaxel in ovarian cancer
    Munster, Mijal
    Blat, Roni
    Roberts, Paul C.
    Schmelz, Eva M.
    Giladi, Moshe
    Schneiderman, Rosa S.
    Porat, Yaara
    Bomzon, Zeev
    Urman, Noa
    Itzhaki, Aviran
    Voloshin, Tali
    Cahal, Shay
    Kirson, Eilon D.
    Weinberg, Uri
    Palti, Yoram
    CLINICAL CANCER RESEARCH, 2016, 22
  • [28] Treatment of gastric cancer cells with tumor treating fields (TTFields) and concomitant FOLFOX
    Flint-Brodsly, Naama
    Zeevi, Einav
    Wainer-Katsir, Kerem
    Fishman, Hila
    Martinez-Conde, Antonia
    Dor-On, Eyal
    Munster, Mijal
    Porat, Yaara
    Voloshin, Tali
    Davidi, Shiri
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Safety and efficacy of Tumor Treating Fields (TTFields) combined with bevacizumab and systemic chemotherapy in recurrent GBM
    Kang, Xun
    Cai, Zehao
    Chen, Feng
    Zhang, Botao
    Jiang, Bo
    Li, Wenbin
    CANCER RESEARCH, 2023, 83 (08)
  • [30] Treatment of pancreatic cancer cells with tumor treating fields (TTFields) and PARP inhibitors
    Ene, Hila
    Ben Meir, Kerem
    Martinez-Conde, Antonia
    Frechtel-Gerzi, Roni
    Gabay, Hila
    Gerasimova, Daria
    Engelman, Rotem
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Palti, Yoram
    CANCER RESEARCH, 2024, 84 (06)
12345